Effects of tyrosine administration on plasma biopterin in patients with juvenile parkinsonism and their relatives
Kondo, T.; Narabayashi, H.; Nagatsu, T.; Yamaguchi, T.; Sawada, M.
Advances in Neurology 45: 217-222
1987
ISSN/ISBN: 0091-3952 PMID: 3825692 Document Number: 302241
Document emailed within 1 workday
Related Documents
O'Keefe, S.J.; Abraham, R.; El-Zayadi, A.; Marshall, W.; Davis, M.; Williams, R. 1981: Increased plasma tyrosine concentrations in patients with cirrhosis and fulminant hepatic failure associated with increased plasma tyrosine flux and reduced hepatic oxidation capacity Gastroenterology 81(6): 1017-1024LeWitt, P.A.; Miller, L.P.; Newman, R.P.; Burns, R.S.; Insel, T.; Levine, R.A.; Lovenberg, W.; Calne, D.B. 1984: Tyrosine hydroxylase cofactor (tetrahydrobiopterin) in parkinsonism Advances in Neurology 40: 459-462
Stoof, J.C.; Koetsier, J.C. 1974: Implications of the formulation of m-tyrosine from DOPA for Parkinsonism Nederlands Tijdschrift Voor Geneeskunde 118(23): 900
Kanzato, N.; Nishihira, T.; Murao, H.; Takara, H. 2006: Case of juvenile parkinsonism in pregnancy Rinsho Shinkeigaku 46(6): 400-403
Rondot, P.; Ziegler, M. 1983: Dystonia--L-dopa responsive or juvenile parkinsonism? Journal of Neural Transmission. Supplementum 19: 273-281
Barreca, T.; Gianrossi, R.; Gallamini, A.; Nizzo, M.C.; Queirolo, A. 1976: Endocrine effects of bromocryptin in patients with Parkinsonism Bollettino della Societa Italiana di Biologia Sperimentale 52(19): 1564-1567
Tursunov, B.; Mazovetskiĭ, A.G.; Zavadskiĭ, P.S. 1978: Disturbed glucose tolerance and diabetes mellitus in the relatives of patients with the juvenile form of diabetes mellitus Problemy Endokrinologii 24(5): 13-16
Zagorovskaia, T.B.; Illarioshkin, S.N.; Slominskiĭ, P.A.; Ivanova-Smolenskaia, I.A.; Markova, E.D.; Limborskaia, S.A.; Levin, O.S.; Miloserdova, O.V.; Proskokova, T.N.; Bagyeva, B.Kh.; Brice, A. 2004: Clinical and genetic analysis of juvenile parkinsonism in Russia Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 104(8): 66-72
Ceulemans, F.; Mahieu, P.; Kets, E.; Wouters, R.; Schneider, Y.J.; Trouet, A. 1983: Follow-up of the plasma concentration of fibronectin in two intensive care patients; effect of administration of plasma cryoprecipitate Acta Clinica Belgica 38(5): 309-314
Seńczuk, W.; Mlynarczyk, W.; Woźniak, D. 1976: Quantitative determination of tyrosine in experimental ferbam 76 poisoning. I. Plasma levels of free tyrosine in experimental animals Roczniki Panstwowego Zakladu Higieny 27(2): 197-208
Nagatsu, T.; Ichinose, H. 1997: GTP cyclohydrolase I gene, dystonia, juvenile parkinsonism, and Parkinson's disease Journal of Neural Transmission. Supplementum 49: 203-209
Williams, T.; Besser, G.M. 1971: Effects of treatment on tyrosine tolerance in thyroid disease. A modified tyrosine assay Clinical Chemistry 17(3): 148-151
González-Calvin, J.L.; Zuluaga Gómez, A.; García-Valdecasas, J.; Núñez Carril, J.; Mora Lara, J.; Peña Angulo, J.F.; Peña Yáñez, A. 1982: Effects of sucrose ingestion on calciuria and other urinary constituents in renal lithiasis patients and in asymptomatic relatives Revista Clinica Espanola 165(5-6): 325-327
Goren, H.J.; Boland, D. 1991: The 180000 molecular weight plasma membrane insulin receptor substrate is a protein tyrosine phosphatase and is elevated in diabetic plasma membranes Biochemical and Biophysical Research Communications 180(2): 463-469
Zafiropoulos, G.G.; Eldanassouri, N.; Flores-de-Jacoby, L.; Havemann, K. 1987: Determination of the ELP (elastase-like proteinase) plasma levels in patients with rapidly advancing and with juvenile periodontitis Deutsche Zahnarztliche Zeitschrift 42(12): 1056-1060
van Dijkhuizen, E.H.Pieter.; Pouw, Jëtte.N.; Scheuern, A.; Hügle, B.; Hardt, S.; Ganser, G.; Kümmerle-Deschner, J.Beate.; Horneff, G.; Holzinger, D.; Bulatović Ćalasan, M.; Wulffraat, N.M. 2016: Methotrexate intolerance in oral and subcutaneous administration in patients with juvenile idiopathic arthritis: a cross-sectional, observational study Clinical and Experimental Rheumatology 34(1): 148-154
Pustorino, S.; Turiano, S.; Pizzimenti, C.; Calipari, G.; Federico, G.; D'Amico, G.; Sinopoli, C.; Martinez, P.; Guerrisi, O.; Luzza, G. 1994: Effects of intravenous administration of clarithromycin on plasma levels of gastrin and group i pepsinogen La Clinica Terapeutica 145(10): 277-281
Touati, G.; Ruiz, J.C.; Porquet, D.; Kindermans, C.; Prieur, A.M.; Czernichow, P. 2000: Effects on bone metabolism of one year recombinant human growth hormone administration to children with juvenile chronic arthritis undergoing chronic steroid therapy Journal of Rheumatology 27(5): 1287-1293
Kryzhanovskiĭ, G.N.; Atadzhanov, M.A.; Magaeva, S.V.; Basharova, L.A.; Vetrilé, L.A. 1989: EEG changes and symptomatic parkinsonism after intracaudate administration of dopamine antibodies Biulleten' Eksperimental'noi Biologii i Meditsiny 107(1): 13-16
Tanji, H.; Nagasawa, H.; Itoh, M.; Itoyama, Y. 1997: PET study of dopamine metabolism and dopamine D2 receptor in juvenile parkinsonism Nihon Rinsho. Japanese Journal of Clinical Medicine 55(1): 89-94